2014/13/N/NZ7/00307
Keywords:
telomerase multidrug resistance breast cancer chemotherapy
Descriptors:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny, Katedra i Zakład Chemii Klinicznej i Diagnostyki Molekularnej
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 7 - announced on 2014-03-17
Amount awarded: 149 910 PLN
Project start date (Y-m-d): 2015-03-05
Project end date (Y-m-d): 2019-03-04
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled